filmov
tv
Dr. Brian Slomovitz, MD – Director, Gynecology OncologyDr Slomovitz Uterine Cancer
Показать описание
• June- Uterine Cancer awareness month
• Most Common variant of uterine cancer is Endometrial Cancer which is inner lining of the uterus- affect women post-menopausal women in their 60’s
• Family history- obesity- different races
• Early signs are post-menopausal bleeding or abnormal bleeding
• Immunotherapy in combination with chemotherapy really helps woman to live longer
FOLLOW LOCAL 10 ON SOCIAL MEDIA:
• Most Common variant of uterine cancer is Endometrial Cancer which is inner lining of the uterus- affect women post-menopausal women in their 60’s
• Family history- obesity- different races
• Early signs are post-menopausal bleeding or abnormal bleeding
• Immunotherapy in combination with chemotherapy really helps woman to live longer
FOLLOW LOCAL 10 ON SOCIAL MEDIA:
Dr. Brian Slomovitz, MD – Director, Gynecology OncologyDr Slomovitz Uterine Cancer
Ways to Ovarcome Ovarian Cancer: Dr. Brian Slomovitz
The TRUTH Behind Clinical Trials In CANCER!
Brian Slomovitz, MD, elaborates on the role of immunotherapy in ovarian cancer
Brian Slomovitz, MD, offers opinion on the repeat use of PARP inhibitors
Brian Slomovitz, MD, on incorporating biomarker-driven therapy in ovarian cancer
Focusing on You: Immunotherapy for Gynecologic Cancer
ASCO2 GYN Cancer Updates | Brian Slomovitz, MD, MS, FACOG | Mount Sinai Medical Center FL
Dr. Slomovitz on the Importance of Developing Sequencing Strategies in Endometrial Cancer
Dr. Slomovitz on the Role of Surgery in Endometrial Cancer
Brian Slomovitz, MD, regarding the long term follow-up data on PARP inhibitors in ovarian cancer
Tisotumab Vedotin for Metastatic Cervical Cancer: Results From ESMO 2023 With Brian Slomovitz, MD
Dr. Slomovitz on Sequencing Strategies for Endometrial Cancer
The Signs and Symptoms of Endometrial Cancer!
Dr. Brian Slomovitz. University of Miami/University of West Indies Gynecologic Oncology Fellowship
The Latest Treatment Options for Ovarian Cancer
Gynecology Updates from ASCO 2017 - Dr. Brian Slomovitz
Dr. Slomovitz Discusses a Study of Everolimus/Letrozole or Hormonal Therapy in Endometrial Cancer
Dr. Slomovitz Discusses a Study of Everolimus/Letrozole or Hormonal Therapy in Endometrial Cancer
Gynecologic Robotic Surgery for Women's Cancer
PARP inhibitors at the crossroads in ovarian cancer: 2022 ESMO Florida
On the Scene at #SGOMtg: Endometrial Cancer Research Highlights
How Different Factors Affect Treatment of Endometrial Cancer
Oncology Research at Atlantic Health System
Комментарии